Skip to main content
. 2023 Sep 24;18(5):100846. doi: 10.1016/j.ajps.2023.100846

Fig. 6.

Fig 6

In vivo efficiency against psoriasis. (A) IL-6 level and (B) TNF-α level of diseased skin after different treantment. (C) SOD activity of diseased skin after different treantment. (D) Immunofluorescence images of diseased skin (red represents ROS). (E-F) H&E-stained diseased skin with different scale bars. (G) Expression of CD3, CD31 and Ki67. Data are expressed as the mean ± SD, n = 3, *P < 0.05, **P < 0.01, ***P < 0.001, compared with the TCeO2-TRA-FNL-Gel group.